Synaptic Localization and Presynaptic Function of Calcium Channel
4-Subunits in Cultured Hippocampal Neurons*
Silke
Wittemann
,
Melanie D.
Mark
,
Jens
Rettig§, and
Stefan
Herlitze
¶
From the
Department of Physiology II, University of
Tuebingen, Ob dem Himmelreich 7, 72074 Tuebingen, Germany and the
§ Department of Membrane Biophysics, Max-Planck-Institute
for Biophysical Chemistry, Am Fassberg 11, 37077 Goettingen,
Germany
Received for publication, May 30, 2000, and in revised form, August 1, 2000
 |
ABSTRACT |
Neurotransmitter release is triggered by the
influx of Ca2+ into the presynaptic terminal through
voltage gated Ca2+-channels. The shape of the presynaptic
Ca2+ signal largely determines the amount of released
quanta and thus the size of the synaptic response.
Ca2+-channel function is modulated in particular by the
auxiliary
-subunits that interact intracellularly with the
pore-forming
1-subunit. Using retrovirus-mediated gene
transfer in cultured hippocampal neurons, we demonstrate that
functional GFP-
4 constructs colocalize with the synaptic
vesicle marker synaptobrevin II and endogenous P/Q-type channels,
indicating that
4-subunits are localized to synaptic
sites. Costaining with the dendritic marker MAP2 revealed that the
4-subunit is transported to dendrites as well as axons.
The nonconserved amino- and carboxyl-termini of the
4-subunit were found to target the protein to the
synapse. Physiological measurements in autaptic hippocampal neurons
infected with green fluorescent protein (GFP)-
4 revealed
an increase in both excitatory post-synaptic current amplitude
and paired pulse facilitation ratio, whereas the GFP-
4
mutant, GFP-
4(
50-407), which demonstrated a
cytosolic localization pattern, did not alter these synaptic
properties. In summary, our data suggest a pre-synaptic function of the
Ca2+-channel
4-subunit in synaptic transmission.
 |
INTRODUCTION |
Ca2+-channels mediate voltage-dependent
Ca2+-influx in subcellular compartments of neurons,
triggering such diverse processes as neurotransmitter release and
excitation-transcription coupling (1, 2). Neuronal
Ca2+-channels consist of a pore-forming
1-subunit and several auxiliary subunits (
-,
2
-, and presumably
-subunits), which are
associated with the
1-subunit. Ca2+-channel
function is determined by different
-subunits, which modify the
gating properties of the channel and most likely the transport of the
1-subunit to the cell surface (3-7). Expression of the
four different
-subunits has been shown in various brain regions
such as the cerebellum and hippocampus. Here,
-subunits were
expressed in neuronal cell bodies, dendrites, and neuropils (8-11). A pre- and post-synaptic localization has been suggested for
1-,
3-, and
4-subunits,
but a precise role for any
-subunit in synaptic transmission has not
been described so far.
New approaches in cell biology to study protein targeting within a
cell, e.g. GFP1
and viral transfection methods, allow the overexpression of ion channel subunits in cultured neuronal cells to analyze their transport to specific subcellular compartments (12). Applying these methods, we
investigated the distribution and specific function of the Ca2+-channel
4-subunit in cultured
hippocampal neurons. We demonstrated that the
4-subunit
is localized to presynaptic terminals and that its N and C termini are
responsible for this specific targeting. Furthermore, we show that
4-subunits of voltage-gated Ca2+-channels
play an important physiological role in synaptic transmission by
altering amplitude and activity-dependent properties of the synaptic response.
 |
EXPERIMENTAL PROCEDURES |
Construction of GFP Fusion Proteins and Deletion
Mutants--
The rat
4 cDNA (13) was amplified with
the following primer pairs, which include restriction sites for
subcloning: 5'-GATCTCGAGATGTCGTCCTCCTACGCCAAG and
3'-ACGGTCGACTCAAAGCCTATGTCGGGAGTC.
The constructs were subcloned in-frame into pEGFP-C3
(CLONTECH) and then excised for cloning into the
Semliki Forest virus vector pSFV1 (Life Technologies, Inc.). Deletion
mutants were constructed using a single PCR reaction where restriction
sites for subcloning into pEGFP-C3
(CLONTECH) were placed within the oligonucleotide
primer. The following primer pairs were used for the deletion
mutants: N terminus (aa 1-49), 5'-GATCTCGAGATGTCGTCCTCCTACGCCAAG and
3'-GGGGGATCCCCCCTGTCTGAGGATGAAGCTGGT; C terminus (aa 408-519), 5'-CCCAAGCTTCCTATGACCCCATTGCTGGGG and
3'-ACGGTCGACTCAAAGCCTATGTCGGGAGTC;
50-407,
5'-GATCTCGAGTCAGCAGATTCCTATACA and
3'-CCCAAGCTTGGTGCTACTGCTTGTGTGGGT.
The pEGFP-C3-
4 deletion clones were
subcloned into pSFV by blunt end cloning and correct orientation
of the constructs were verified by cDNA sequencing. cDNAs
encoding
4 (13), GFP-
4, and
GFP-
4(
50-407) in pEGFP-C3
(CLONTECH) were used for whole cell
recordings. Western blotting of infected HEK293 cells with a monoclonal
anti-GFP antibody (CLONTECH) was performed
according to standard procedures as described by Mark et al.
(14).
Cell Culture and Electrophysiology--
HEK293 cells were
transfected with the Ca2+-channel subunits
1A,
2
, and
4,
GFP-
4, or GFP-
4(
50-407). cDNAs
and whole cell recordings were performed as published previously (15).
Membrane capacitance and series resistance were compensated
electronically using the patch clamp amplifier (EPC-9; HEKA, Lambrecht,
Germany). Voltage protocol design and data acquisition were performed
using Pulse++, version 1.7 software (Ulix GmbH, Tuebingen, Germany) on
a Macintosh Power PC. Inactivation measurements for control of
functional GFP constructs (Figs. 1 and 5) were performed with 10 mM Ba2+ as the current carrier at room
temperature. 2- and 10-ms inactivation protocols were measured with 4 mM Ca2+ instead of Ba2+ as the
current carrier, also at room temperature (extracellular solution in
mM: 100 Tris, 4 MgCl2, 4 CaCl2, pH
7.3, with methanesulfonic acid). Ca2+- and
Ba2+-currents were analyzed using the IGOR data analysis
package (WaveMetrics, Lake Oswego, OR). Peak currents were determined
from the current measured at +10 mV. Currents were elicited by a 500-ms
voltage ramp from
70 mV to +50 mV. Time constants of inactivation
(
-inact) were determined by fitting the decay phase of a 1000-ms
test pulse from
70 mV to +10 mV with a single exponential or, as
shown in Fig. 9, by fitting the decreasing tail currents elicited by 2- or 10-ms test pulses from
70 mV to +10 mV every 50 ms with a single
exponential. The percent current reduction was determined by comparing
the size of the first elicited tail current and the last elicited tail
current with the 20 Hz stimulation protocol. 20 test pulses were
applied within the 20 Hz stimulation protocol in HEK293 cells.
Statistical significance was expressed as ** p < 0.01. All error values (±) and bars in this publication are S.E.s.
Micro-island cultures of hippocampal neurons were prepared according to
a modified version of published procedures (16). After 9-14 days in
culture, cells were infected with 50 µl of an activated Semliki
Forest virus containing the cDNAs of GFP-
4 or
GFP-
4-deletion constructs following a protocol given in
Ashery et al. (17). All measurements were performed 6-18 h
after infection. Only dots containing a single neuron forming
excitatory synapses (autapses) were used. Extracellular recording
solution contained (in mM): 172 NaCl, 2.4 KCl, 10 HEPES, 10 glucose, 4 CaCl2, 4 MgCl2, and 0.03 CdCl2 (pH 7.3, 350 mosmol). Patch pipettes (2-3
megaohms) were pulled from borosilicate glass (TWF 150, World Precision Instruments) on a Sutter puller and back-filled with the
following (in mM): 145 potassium gluconate, 15 HEPES, 1 potassium-EGTA, 4 Na-ATP, 0.4 Na-GTP (pH 7.3). Currents were recorded
and analyzed as published previously by Lao et al. (18).
Immunocytochemistry--
Continental hippocampal cultures were
prepared and infected as described above and fixed as described by Mark
et al. (14). Neurons were incubated with synaptobrevin II
antibody (C69.1 at 1:1000, a gift from R. Jahn, Göttingen,
Germany), Ca2+-channel
1A-subunit antibody
(Chemicon; 1:60) or MAP2 antibody (Sigma; 1:1000) and then with an
Alexa 546-coupled secondary antibody (Molecular Probes, Leiden,
Netherlands). Cells were embedded in Fluoromount (133 mM
Tris-HCl, 30% glycerol, 11% Mowiol, 2%
diazabicyclo(2.2.2)octane. Fluorescence was detected with a
conventional fluorescence microscope (Axiophot; Carl Zeiss, Oberkochen,
Germany), and images were analyzed with the Metamorph imaging system.
 |
RESULTS |
A fusion construct between GFP and the
4-subunit
was generated to analyze the distribution and function of this
Ca2+-channel subunit (Fig.
1a). The GFP was tagged in
frame to the N terminus of the
4-subunit using the
mammalian expression vector pEGFP-C3 and subcloned into the
Semliki Forest virus vector (pSFV). We first investigated whether the
fusion construct of the virus expresses a protein of the correct size.
Western blot analysis of HEK293 cells infected with
GFP-
4 revealed an 83-kDa band, the predicted size of the
GFP-
4 fusion protein (Fig. 1b). In addition,
the GFP-
4 protein assembled with the
1A-
and
2
-subunits to form a functional voltage-gated
Ca2+-channel in HEK293 cells. Whole cell peak currents were
measured at +10 mV during a 500-ms voltage ramp from
70 to +50 mV and increased from
38 ± 14 pA (n = 7) for
1A/
2
to
602 ± 314 pA (n = 11) with the GFP-
4 fusion protein,
which was comparable to the wild-type
4 currents
(-744 ± 209 pA (n = 23)) (Fig. 1c). In
addition, GFP-
4 revealed the characteristic slow
inactivation time constants at 0, +5, +10, and +15 mV (
-inact) as
described for wild-type
4-subunit assembled with
P/Q-type Ca2+-channels (188 ± 22 (0 mV), 145 ± 18 (+5 mV), 131 ± 18 (+10 mV), and 130 ± 15 ms (+15 mV)
(n = 6) for wild-type-
4; (178 ± 29 (0 mV), 149 ± 18 (+5 mV), 136 ± 12 (+10 mV), and 147 ± 22 ms (+15 mV) (n = 6) for GFP-
4)
(Fig. 1d) (19). Thus, GFP-
4 constructs yield
functional
4-protein, which alters the
electrophysiological characteristics of the P/Q-type
Ca2+-channels in the expected manner.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 1.
Western blot analysis and whole cell
recordings of HEK293 cells expressing
GFP- 4. a, schematic
representation of the GFP- 4 fusion construct used in the
experiments described. GFP was tagged in-frame to the N terminus of
4. The 4-subunit consists of 519 aa.
b, Western blot analysis of GFP and GFP- 4
expressed in HEK293 cells. Proteins were detected with a monoclonal
antibody against GFP. Purified GFP- 4 protein shows the
expected size of 83 kDa. c, whole cell recordings of HEK293
cells cotransfected with the 1A, 2 ,
and GFP- 4 or wild-type- 4.
Left, representative Ba2+-currents from an
1A, 2 , and GFP- 4
assembled channels were elicited by 4-ms, 5-mV step potentials from
50 to +50 mV from a holding potential of 70 mV. Right,
Ba2+-currents were measured at +10 mV during the 500-ms
voltage ramps. Bars represent cells transfected with the
following DNAs: black bar, 1A,
2 , and GFP; white bar, 1A,
2 , wild-type- 4, and GFP; gray
bar, 1A, 2 , and
GFP- 4. The Ba2+-currents are significantly
larger for cells expressing the 4-subunit
(p > 0.01, two-tailed t test) but are not
significantly different between wild-type 4 and
GFP- 4. d, left, representative traces of
Ba2+-currents from 1A, 2 ,
and GFP- 4 assembled channels elicited by a 1000-ms test
pulse to 50, 0, +5, +10, and +15 mV from a holding potential of 70
mV. Right, time constants for inactivation curves ( -inact
in ms) measured at 0, +5, +10, and +15 mV. Values for
1A, 2 , and wild-type 4
(open circles) or GFP- 4 (filled
diamonds) are not significantly different.
|
|
To investigate the distribution of
4 in hippocampal
neurons, 9-14-day-old neurons were infected with the
GFP-
4 construct using the Semliki Forest virus gene
expression system. Overexpressed GFP-
4-subunits
displayed a punctate staining pattern along the neuronal processes
(Fig. 2, a-c), as observed
for vesicle-transported proteins like synaptobrevin II, syntaxin, or
syntaphilin, whereas overexpressed GFP alone showed a diffuse,
cytosolic distribution along the neurites (Fig. 2, d-f).
Colocalization with the synaptic vesicle marker synaptobrevin II (Fig.
2c) revealed that GFP-
4 was indeed transported to
synaptic sites. P/Q-type Ca2+-channels are highly expressed
in presynaptic terminals (20) and play a fundamental role in synaptic
transmission (2). Because
4-subunits can assemble with
1A-subunits to form functional channels in HEK293 cells
(Fig. 1), we investigated whether
4-subunits colocalize
with endogenous presynaptic Ca2+-channels in hippocampal
neurons. Costaining between the
1A-subunit encoding for
the P/Q-type channel and GFP-
4 demonstrated the colocalization of both proteins (Fig. 3).
Next, we investigated whether the
4-subunit is localized
to dendrites or axons. Double-labeling with the dendritic marker MAP2
identified the fact that GFP-
4 is transported to both
dendrites and axons (Fig. 4). Thus, our results highly suggest that the
4-subunit is targeted to
synaptic sites.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Colocalization of
GFP- 4 with synaptobrevin II in
cultured hippocampal neurons. a, fluorescence patterns
of neurons from low density hippocampal cultures infected with
GFP- 4 reveal a punctate staining. b,
hippocampal cells were stained with an anti-synaptobrevin II antibody
and visualized with an Alexa 546-coupled secondary antibody. A punctate
staining pattern similar to that seen with GFP- 4 was
observed. c, overlay of a and b in the
indicated area demonstrates that GFP- 4 is
partially colocalized with the synaptic vesicle marker synaptobrevin II
(yellow). d, fluorescence pattern of neurons from
low density hippocampal cultures infected with GFP alone demonstrates a
diffuse, cytosolic staining. e, hippocampal cells were
stained with an anti-synaptobrevin II antibody and visualized with an
Alexa 546-coupled secondary antibody. f, overlay of
d and e in the indicated area demonstrates that
GFP is not colocalized with the synaptic vesicle marker synaptobrevin
II (yellow). Scale bars in a, b, d,
and e =10 µm and in c and f = 2 µm.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Colocalization of
GFP- 4 with
Ca2+-channel
1A-subunit in cultured hippocampal
neurons. a, fluorescence patterns of neurons from low
density hippocampal cultures infected with GFP- 4 reveal
a punctate staining. b, hippocampal cells were stained with
an anti- 1A antibody and visualized with an Alexa
546-coupled secondary antibody. A punctate staining pattern similar to
that seen with GFP- 4 was observed. c, overlay
of a and b in the indicated area
demonstrates that GFP- 4 is partially colocalized
with the presynaptic P/Q-type Ca2+-channel subunit
1A (yellow). Scale bars in
a and b = 10 µm and in c = 5 µm.
|
|

View larger version (83K):
[in this window]
[in a new window]
|
Fig. 4.
Localization of
GFP- 4 and MAP2 in cultured
hippocampal neurons. a, fluorescence patterns of
neurons from low density hippocampal cultures infected with
GFP- 4 reveal staining in dendrites and axons.
b, hippocampal cells were stained with an anti-MAP2 antibody
and visualized with an Alexa 546-coupled secondary antibody. MAP2
stains only the dendrites and not the axon. Scale bars = 10 µm.
|
|
Based on the sequence alignment, the predicted structure of
1b-subunit, and functional analysis,
-subunits can be
divided into five domains (21, 22) (Fig.
5a). A high degree of
conservation among the
-subunits was observed for domains
II and IV, but not for domains I (N
terminus), III, and V (C terminus). To determine
which domain of
4 is responsible for targeting this
subunit to its specific subcellular localization, we produced several
deletion constructs of GFP-
4 according to the domain
assignment (Fig. 5a). These constructs expressed fusion proteins of the expected size (Fig. 5b). The minimal
segments required for punctate localization and colocalization with
synaptobrevin II were domain I (N terminus, aa 1-49) and
domain V (C terminus, aa 408-519) of the
4-subunit. 97% of the cells infected with the C
terminus and 72% of the cells infected with the N terminus colocalized
with synaptobrevin II and showed a punctate pattern (Table
I). Thus, either N or C terminus alone is
sufficient for colocalization with synaptobrevin II (Fig.
6, a-f). In contrast, a deletion construct lacking both the N and C termini (aa 50-407; domains II-IV), such as GFP alone, revealed a
homogenous, cytosolic localization. 72% of these cells showed no
synaptobrevin II colocalization (Fig. 6, g-i) (data
summarized in Table I). The punctate staining pattern and its
colocalization with synaptobrevin II indicates that the N and C termini
of GFP-
4 are sufficient for synaptic targeting.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
GFP- 4 deletion
constructs. a, schematic representation of
4 domain structure and derived deletion constructs. The
-subunit is divided into 5 domains (I, II,
III, IV, V). The black bars
represent the domains with a high degree of conservation between all
four -subunit isoforms ( 1b, 3,
2a, and 4), and the gray bars
represent domains with a low degree of conservation (22, 41).
b, Western blot analysis of GFP and GFP- 4
deletion constructs expressed in HEK293 cells. Proteins were detected
as described in Fig. 1b legend. c, whole cell
recordings of HEK293cells cotransfected with 1A,
2 , and with or without
GFP- 4( 50-407). Left, representative
Ba2+-currents from 1A, 2 ,
and GFP- 4( 50-407) assembled channels were elicited
by 4-ms, 5-mV step potentials from 50 to +50 mV from a holding
potential of 70 mV. Right, Ba2+-currents were
measured at +10 mV during 500-ms voltage ramps. Bars
represent cells transfected with the following DNAs: black
bar, 1A, 2 , and GFP;
striped bar, 1A, 2 , and
GFP- 4( 50-407). The Ba2+-currents are
significantly larger for cells expressing the
GFP- 4( 50-407) construct (p > 0.01, two-tailed t test). d, left, representative
traces of a Ba2+-currents from 1A,
2 , and GFP- 4( 50-407) assembled
channels elicited by a 1000-ms test pulse to 50, 0, +5, +10, and +15
mV from a holding potential of 70 mV. Right, time
constants for inactivation curves ( -inact in ms) measured at 0, +5,
+10, and +15 mV. Values for Ca2+-channels assembled with
the GFP- 4 (open circles) or
GFP- 4( 50-407) (filled squares) are not
significantly different.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Statistical analysis of punctate staining pattern in hippocampal
neurons infected with various 4 constructs
Low density hippocampal cultures were prepared and infected with
various 4 constructs after 9-14 days in culture, fixed, and
analyzed as described under "Experimental Procedures."
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 6.
Distribution and colocalization of
GFP- 4 deletion constructs with
synaptobrevin II in cultured hippocampal neurons. a, d,
and g, fluorescence patterns of neurons from low density
hippocampal cultures infected with GFP- 4 deletion
constructs (a, N terminus; d, C terminus;
g, GFP- 4( 50-407)). b, e, and
h, hippocampal cells were stained with an anti-synaptobrevin
II antibody and visualized with an Alexa546-coupled secondary antibody.
c, f, and i, overlays of a and
b (N terminus), d and e (C terminus),
and g and h (GFP- 4( 50-407))
demonstrate that GFP- 4-N terminus and
GFP- 4-C terminus (domains I and
V), but not GFP- 4( 50-407), are
colocalized with the synaptic vesicle marker synaptobrevin II
(yellow). Scale bars = 10 µm for
a, b, d, e, g,
and h and 2 µM for c, f,
and i.
|
|
To investigate the physiological role of GFP-
4, we
measured EPSCs in the whole cell, voltage clamp configuration from
autaptic hippocampal neurons infected with GFP-
4
and GFP-
4(
50-407) and compared them with the EPSCs
from noninfected neurons. As shown in Fig. 5, c and
d, GFP-
4(
50-407) assembled to form a
functional Ca2+-channel when expressed together with the
1A- and
2
-subunit in HEK293 cells. The
channel revealed inactivation properties comparable with the
GFP-
4 assembled channels and increased the whole cell
peak current measured at +10 mV (
1A,
48 ± 4 pA
(n = 5);
1A/
2
/GFP-
4(
50-407),
1715 ± 390 pA (n = 17)). Since GFP-
4(
50-407) did not colocalize with synaptobrevin
II, specific presynaptic effects on synaptic transmission should become
obvious only in the presence of GFP-
4, but not in the
presence of GFP-
4(
50-407). Recordings were performed
in the presence of 30 µM Cs2+, which reduces
the EPSC amplitude by
>90%,2 to more easily
detect changes in EPSC size and facilitation properties between
infected and noninfected cells. EPSC amplitudes for infected cells were
related to the average EPSC size measured for noninfected autaptic
hippocampal neurons prepared and measured on the same day. The average
EPSC size increased drastically from 100 ± 20% (n = 46) for noninfected neurons to 334 ± 63%
(n = 40, p < 0.01) for
GFP-
4-infected neurons, but decreased for
GFP-
4(
50-407) infected neurons to 50 ± 17%
(n = 34) (Fig. 7,
a and b), indicating an increased transmitter
release in the presence of GFP-
4 but not
GFP-
4(
50-407).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
Effects of
GFP- 4 and
GFP- 4( 50-407)
on EPSC amplitude of autaptic hippocampal neurons. a,
representative autaptic EPSC traces from noninfected neurons and
infected GFP- 4( 50-407) and GFP- 4
neurons. EPSCs were elicited by a 2-ms depolarizing pulse to +10 mV.
b, mean autaptic EPSC amplitude at 0.2 Hz stimulation in
isolated hippocampal neurons. Right, EPSCs of infected
neurons were compared with EPSCs of noninfected hippocampal cells
(control 1 and control 2) recorded from the same
cell preparation. The average EPSC amplitude from
GFP- 4-infected neurons was significantly larger
(p < 0.01; two-tailed t test) than
noninfected neurons, whereas the average EPSC amplitude from
GFP- 4( 50-407) infected neurons was reduced compared
with noninfected neurons. However, the effect was not significant.
Left, EPSCs were related to the EPSCs of noninfected
hippocampal cells recorded on the same day. c, number of
EPSC measurements in hippocampal cells in percent for noninfected
(control) and infected GFP- 4 and
GFP- 4( 50-407) hippocampal neurons. Autaptic EPSCs
recordings from hippocampal neurons were categorized in 3 groups: no
EPSC could be detected, EPSC amplitudes smaller than 100 pA, and EPSC
amplitudes larger than 100 pA. The diagram reveals that 58%
(control 1) and 41% (control 2) of noninfected,
57% of GFP- 4( 50-407)-infected, and only 18% of
GFP- 4-infected hippocampal neurons have EPSCs smaller
than 100 pA, whereas 54% of GFP- 4-infected hippocampal
neurons and only 23% (control 1) and 31% (control
2) of noninfected and 21% of
GFP- 4( 50-407)-infected hippocampal neurons have
EPSCs larger than 100 pA. Number of neurons examined: control 1 = 57; control 2 = 29; GFP- 4 = 56;
GFP- 4( 50-407) = 44.
|
|
Short term synaptic enhancements during repetitive synaptic activity
are attributable to a presynaptic increase in the number of transmitter
quanta released. Ca2+ entry during the conditioning
stimulation is required for their induction (23, 24). We therefore
analyzed the effects of GFP-
4 and
GFP-
4(
50-407) on the facilitation properties of
autaptic hippocampal neurons for EPSCs, which were larger than 80 pA
and of comparable size in the infected and noninfected neurons. The ratios between the amplitudes of the first evoked EPSCs and the fourth
evoked EPSCs for low and high frequency stimulations were determined.
Low frequency stimulation (0.2 Hz) produced no EPSC facilitation in
control (0.83 ± 0.04 (n = 59)),
GFP-
4-infected (0.86 ± 0.05 (n = 33)), or GFP-
4(
50-407)-infected (0.92 ± 0.06 (n = 24)) cells (Fig. 8,
a and b). In contrast, high frequency stimulation
(20 Hz) led to paired pulse facilitation of EPSCs. More importantly,
paired pulse facilitation is increased significantly from 1.47 ± 0.07 (n = 44) in control cells to 2.67 ± 0.29 (n = 39) in GFP-
4-infected cells
(p < 0.01) but not in
GFP-
4(
50-407)-infected cells (1.17 ± 0.06 (n = 25)) (Fig. 8, c and d),
indicating a presynaptic function of GFP-
4 on paired
pulse facilitation.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 8.
Effects of
GFP- 4 and
GFP- 4( 50-407)
on paired pulse facilitation of autaptic hippocampal neurons.
a, representative autaptic EPSC traces from noninfected
neurons (control) and neurons infected with
GFP- 4 or GFP- 4( 50-407), respectively.
30 EPSCs were elicited at 0.2 Hz stimulation; the first and fourth
EPSCs of one representative experiment are shown. b, EPSC
ratios for 0.2 Hz stimulation are not significantly different between
hippocampal neurons (control, white bar) and
neurons infected with GFP- 4 (dark gray bar)
or GFP- 4( 50-407) (light gray bar).
c, representative autaptic EPSC traces from hippocampal
neurons (control) and neurons infected with
GFP- 4 or GFP- 4( 50-407), respectively.
30 EPSCs were elicited at 20 Hz stimulation and the first and fourth
EPSCs of one representative experiment are shown. d, EPSC
ratios for 20 Hz stimulation are significantly different between
noninfected neurons (control; white bar) or
GFP- 4( 50-407) (light gray bar)- and
GFP- 4 (dark gray bar)-infected neurons
(p < 0.01, two-tailed t test). EPSC ratios
were calculated by dividing the amplitude of the first EPSC by the
fourth EPSC within each set of experiment.
|
|
To investigate whether the gating properties of a specific
Ca2+-channel type assembled with different
-subunits may
account for the altered facilitation properties observed with
overexpressed
4-subunits in cultured hippocampal
neurons, we analyzed Ca2+-currents (ICa2+)
during high frequency stimulation of P/Q-type channels assembled with
4 and
1b. We transfected HEK293 cells
with
1A/
2
and
4 or
1b, respectively, and elicited ICa2+ by
a 20 Hz stimulation protocol. P/Q-type channels assembled with the
1b-subunit inactivated faster (32.5 ± 2.1 ms
(n = 21)) and to a higher degree (87 ± 2%
(n = 17)) than channels assembled with the
4-subunit (54.9 ± 7.5 ms (n = 31); 74 ± 2% (n = 25)) when 10-ms test pulses to +10
mV were applied (Fig. 9). 20 Hz
application of 2-ms test pulses to +10 mV had no effect on the size of
P/Q-type channel currents assembled with
4, whereas
ICa2+ through
1b assembled channels decreased slowly (249 ± 22 ms (n = 20) by
22.5 ± 1.8%) (Fig. 9). Thus, the assembly of P/Q-type
Ca2+-channel with different
-subunits at the presynapses
may be responsible for the increased facilitation in the presence of
overexpressed
4.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 9.
Effects of high frequency stimulation on
P/Q-type Ca2+-currents in HEK293 cells. a,
representative ICa2+ traces from HEK293 cells
transfected with 1A, 2 , and
4 (left traces) and 1A,
2 , and 1b (right traces).
20 tail currents were elicited by a 2-ms (upper traces) or
10-ms (lower traces) voltage pulse from 70 mV to +10 mV
every 50 ms (20 Hz stimulation). b, inactivation time
constants for P/Q-type channels assembled with 1b or
4 were determined by fitting the decreasing tail
currents with a single exponential. Inactivation time constant for
P/Q-type channels assembled with 4 for the 2-ms test
pulse could not be determined (n.d.) c, a larger
reduction in ICa2+ is evident with 1b-
compared with 4-transfected cells following 2- and 10-ms
test pulses. The percent current reduction was determined by comparing
the size of the first elicited tail current and the last elicited tail
current within the stimulation protocol.
|
|
 |
DISCUSSION |
In this study, we describe the synaptic distribution and function
of the Ca2+-channel
4-subunit in cultured
hippocampal neurons. Overexpression of a functional
GFP-
4 fusion protein in cultured hippocampal neurons
revealed a punctate staining pattern similar to the distribution of
synaptic proteins synapsin I, synaptophysin (25), Munc-13-1 (26), syntaphilin (18), and synaptobrevin (27, 28). Colocalization of
GFP-
4 with synaptobrevin II, a highly enriched
presynaptic vesicle protein involved in transmitter release (29), and
the presynaptic P/Q-type Ca2+-channel
1A-subunit suggests that GFP-
4 is also
targeted to the presynaptic terminals. The recent finding that
1A and synaptobrevin are colocalized in mobile transport
packets in hippocampal neurons (30) supports our results. Targeting
signals to specific organelles have been identified in the
extracellular and transmembrane domains of various proteins (31, 32).
Infection of cultured hippocampal neurons with viral vectors is useful
for identifying specific axonal sorting signals. For example,
synaptobrevin contains a 92-aa long N-terminal region that is
responsible for axonal targeting (28), whereas the metabotropic
glutamate receptor 7 contains a 60-aa long cytoplasmic domain
that mediates both axonal and dendritic targeting (33). To detect
sequences responsible for targeting the
4-subunit to
presynaptic sites, we made use of the functional map and domain
assignments suggested by Walker and De Waard (21) and Hanlon et
al. (22). The identity of the N and C termini domains is
only 2-3%, and these domains may therefore encode for different
targeting signals among the
-subunits as suggested by the
colocalization of the N and C termini GFP fusion constructs with
synaptobrevin. In addition, a
1b-specific acidic
sequence in the C terminus has been described as responsible for
membrane association of the
1b-subunit (34). A
comparison of the targeting sequences from the
4-subunit
and the presynaptically transported proteins synaptobrevin II and
mGluR7 did not reveal any homology. Therefore, the N- and C-terminal
targeting sequences of Ca2+-channel
4-subunit are distinct from other known presynaptic targeting signals. Interestingly, the C terminus of
4
has been identified as a specifc, low affinity interaction site with
the C terminus of
1A (35). The specific interaction
between
1A- and
4-subunits and the
targeting to the presynapse mediated by
4 may indicate
how P/Q-type Ca2+-channel complexes are assembled at the
presynapse. However, the assembly of
4-subunits with
other
1-subunits at the presynapse cannot be excluded.
Physiological studies point to a presynaptic function of the
Ca2+-channel
4-subunit. For example, in
lethargic mice where no functional
4-subunit is
expressed (36), the excitatory synaptic transmission in the thalamus
and hippocampus, as well as the KCl-induced Ca2+-uptake
through P/Q-type channels in thalamic and neocortical synaptosomes, is
reduced (37-39). In our study, we demonstrate a synaptic function of
4-subunits in synaptic transmission because overexpression of GFP-
4 but not
GFP-
4(
50-407) increased EPSC amplitude and paired
pulse facilitation. One of the factors contributing to facilitation and
EPSC size is the amount of Ca2+-influx into the presynaptic
terminal through voltage-gated Ca2+-channels.
-subunits
have been described as determining the transport of the pore-forming
1-subunits to the cell surface and increasing the number
of channels in the plasma membrane (3-7). An increase in the
presynaptic Ca2+-channel concentration may account for the
larger EPSC amplitudes due to a higher release probability. We
therefore measured somatic non-L-type Ca2+-currents in
GFP-
4 infected and noninfected hippocampal neurons and
observed a slight but not significant increase in current amplitude for
GFP-
4 infected cells (
0.748 ± 0.255 nA
(n = 9)) compared with noninfected neurons
(
0.446 ± 0.123 nA (n = 9)). Thus, other effects
leading to an increase in EPSC amplitude and facilitation cannot be
excluded. For example, if the Ca2+-channel concentration at
autaptic synapses does not change and the release probability at a
single synapse is not affected by overexpression of
4,
then the successful transmission for a given action potential
would remain unchanged. The formation of new synaptic contacts, new
active sites, or postsynaptic effects, such as an increase in ligand
gated cation channels, would explain our results. However, the altered
facilitation properties point to a presynaptic mechanism.
The increase in the paired pulse facilitation ratio may reflect the
slow inactivation time of presynaptic Ca2+-channels
assembled with the
4-subunit for a limited access of Ca2+, because
4 causes
Ca2+-channels to inactivate slower compared with channel
complexes containing
1b or
3 (19, 40).
This hypothesis is underlined by our results showing that in the
presence of
4-subunits, inactivation is slower and
current reduction is decreased compared with P/Q-type channels
expressed with
1b. Therefore, Ca2+-channel
complexes containing
4-subunits at the presynapse may contribute to increased synaptic facilitation.
In summary, our findings suggest a presynaptic function of
Ca2+-channel
4-subunits in synaptic
transmission. The specific targeting of
4 depends
on its nonconserved N and C termini, which is critical for
the localization of the subunit to synaptic terminals and for the short
term modulation of synaptic transmission.
 |
ACKNOWLEDGEMENTS |
We thank B. Rudo, A. Bührmann, and I. Herfort for excellent technical assistance. We are grateful to Drs.
T. P. Snutch and E. Perez-Reyes for cDNAs, Dr. R. Jahn for the
monoclonal antibody to synaptobrevin II, Dr. C. Rosenmund for
helpful comments, and Drs. J. P. Ruppersberg and E. Neher for
generous support.
 |
FOOTNOTES |
*
This work was supported by grants from the Deutsche
Forschungsgemeinschaft (He2471/5-1 to S. H. and Re1092/3-2 to J. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.:
049-7071-2978279; Fax: 049-7071-87815; E-mail:
stefan.herlitze@uni- tuebingen.de.
Published, JBC Papers in Press, August 7, 2000, DOI 10.1074/jbc.M004653200
 |
ABBREVIATIONS |
The abbreviations used are:
GFP, green
fluorescent protein;
aa, amino acid(s);
EPSC, excitatory post-synaptic
current;
HEK, human embryonic kidney.
 |
REFERENCES |
| 1.
|
Catterall, W. A.
(1998)
Cell Calcium
24,
307-323
|
| 2.
|
Dunlap, K.,
Luebke, J. I.,
and Turner, T. J.
(1995)
Trends Neurosci.
18,
89-98
|
| 3.
|
Gregg, R. G.,
Messing, A.,
Strube, C.,
Beurg, M.,
Moss, R.,
Behan, M.,
Sukhareva, M.,
Haynes, S.,
Powell, J. A.,
Coronado, R.,
and Powers, P. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13961-13966
|
| 4.
|
Yamaguchi, H.,
Hara, M.,
Strobeck, M.,
Fukasawa, K.,
Schwartz, A.,
and Varadi, G.
(1998)
J. Biol. Chem.
273,
19348-19356
|
| 5.
|
Gerster, U.,
Neuhuber, B.,
Groschner, K.,
Striessnig, J.,
and Flucher, B. E.
(1999)
J. Physiol. (Lond.)
517,
353-368
|
| 6.
|
Birnbaumer, L.,
Qin, N.,
Olcese, R.,
Tareilus, E.,
Platano, D.,
Costantin, J.,
and Stefani, E.
(1998)
Bioenerg. Biomembr.
30,
357-375
|
| 7.
|
Bichet, D.,
Cornet, V.,
Geib, S.,
Carlier, E.,
Volsen, S.,
Hoshi, T.,
Mori, Y.,
and M., D. W.
(2000)
Neuron
25,
177-190
|
| 8.
|
Ludwig, A.,
Flockerzi, V.,
and Hofmann, F.
(1997)
J. Neurosci.
17,
1339-1349
|
| 9.
|
Day, N. C.,
Volsen, S. G.,
McCormack, A. L.,
Craig, P. J.,
Smith, W.,
Beattie, R. E.,
Shaw, P. J.,
Ellis, S. B.,
Harpold, M. M.,
and Ince, P. G.
(1998)
Brain Res. Mol. Brain Res.
60,
259-269
|
| 10.
|
Volsen, S. G.,
Day, N. C.,
McCormack, A. L.,
Smith, W.,
Craig, P. J.,
Beattie, R. E.,
Smith, D.,
Ince, P. G.,
Shaw, P. J.,
Ellis, S. B.,
Mayne, N.,
Burnett, J. P.,
Gillespie, A.,
and Harpold, M. M.
(1997)
Neuroscience
80,
161-174
|
| 11.
|
Lie, A. A.,
Blumcke, I.,
Volsen, S. G.,
Wiestler, O. D.,
Elger, C. E.,
and Beck, H.
(1999)
Neuroscience
93,
449-456
|
| 12.
|
Jareb, M.,
and Banker, G.
(1998)
Neuron
20,
855-867
|
| 13.
|
Castellano, A.,
Wei, X.,
Birnbaumer, L.,
and Perez-Reyes, E.
(1993)
J. Biol. Chem.
268,
12359-12366
|
| 14.
|
Mark, M. D.,
Liu, Y.,
Wong, S. T.,
Hinds, T. R.,
and Storm, D. R.
(1995)
J. Cell Biol.
130,
701-710
|
| 15.
|
Herlitze, S.,
Garcia, D. E.,
Mackie, K.,
Hille, B.,
Scheuer, T.,
and Catterall, W. A.
(1996)
Nature
380,
258-262
|
| 16.
|
Bekkers, J. M.,
and Stevens, C. F.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
7834-7838
|
| 17.
|
Ashery, U.,
Betz, A.,
Xu, T.,
Brose, N.,
and Rettig, J.
(1999)
Eur. J. Cell Biol.
78,
525-532
|
| 18.
|
Lao, G.,
Scheuss, V.,
Gerwin, C. M.,
Su, Q.,
Mochida, S.,
Rettig, J.,
and Sheng, Z. H.
(2000)
Neuron
25,
191-201
|
| 19.
|
Stea, A.,
Tomlinson, W. J.,
Soong, T. W.,
Bourinet, E.,
Dubel, S. J.,
Vincent, S. R.,
and Snutch, T. P.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10576-10580
|
| 20.
|
Westenbroek, R. E.,
Hoskins, L.,
and Catterall, W. A.
(1998)
J. Neurosci.
18,
6319-6330
|
| 21.
|
Walker, D.,
and De Waard, M.
(1998)
Trends Neurosci.
21,
148-154
|
| 22.
|
Hanlon, M. R.,
Berrow, N. S.,
Dolphin, A. C.,
and Wallace, B. A.
(1999)
FEBS Lett.
445,
366-370
|
| 23.
|
Fisher, S. A.,
Fischer, T. M.,
and Carew, T. J.
(1997)
Trends Neurosci.
20,
170-177
|
| 24.
|
Zucker, R. S.
(1999)
Curr. Opin. Neurobiol.
9,
305-313
|
| 25.
|
Fletcher, T. L.,
Cameron, P.,
De Camilli, P.,
and Banker, G.
(1991)
J. Neurosci.
11,
1617-1626
|
| 26.
|
Betz, A.,
Ashery, U.,
Rickmann, M.,
Augustin, I.,
Neher, E.,
Sudhof, T. C.,
Rettig, J.,
and Brose, N.
(1998)
Neuron
21,
123-136
|
| 27.
|
Li, J. Y.,
Edelmann, L.,
Jahn, R.,
and Dahlstrom, A.
(1996)
J. Neurosci.
16,
137-147
|
| 28.
|
West, A. E.,
Neve, R. L.,
and Buckley, K. M.
(1997)
J. Cell Biol.
139,
917-927
|
| 29.
|
Elferink, L. A.,
Trimble, W. S.,
and Scheller, R. H.
(1989)
J. Biol. Chem.
264,
11061-11064
|
| 30.
|
Ahmari, S. E.,
Buchanan, J.,
and Smith, S. J.
(2000)
Nat. Neurosci.
3,
445-451
|
| 31.
|
Keller, P.,
and Simons, K.
(1997)
J. Cell Sci.
110,
3001-3009
|
| 32.
|
Bradke, F.,
and Dotti, C. G.
(1998)
Biochim. Biophys. Acta
1404,
245-258
|
| 33.
|
Stowell, J. N.,
and Craig, A. M.
(1999)
Neuron
22,
525-536
|
| 34.
|
Bogdanov, Y.,
Brice, N. L.,
Canti, C.,
Page, K. M.,
Li, M.,
Volsen, S. G.,
and Dolphin, A. C.
(2000)
Eur. J. Neurosci.
12,
894-902
|
| 35.
|
Walker, D.,
Bichet, D.,
Campbell, K. P.,
and De Waard, M.
(1998)
J. Biol. Chem.
273,
2361-2367
|
| 36.
|
McEnery, M. W.,
Copeland, T. D.,
and Vance, C. L.
(1998)
J. Biol. Chem.
273,
21435-21438
|
| 37.
|
Caddick, S. J.,
Wang, C.,
Fletcher, C. F.,
Jenkins, N. A.,
Copeland, N. G.,
and Hosford, D. A.
(1999)
J. Neurophysiol.
81,
2066-2074
|
| 38.
|
Qian, J.,
and Noebels, J. L.
(2000)
J. Neurosci.
20,
163-170
|
| 39.
|
Lin, F.,
Barun, S.,
Lutz, C. M.,
Wang, Y.,
and Hosford, D. A.
(1999)
Brain Res. Mol. Brain Res.
71,
1-10
|
| 40.
|
Brody, D. L.,
and Yue, D. T.
(2000)
J. Neurosci.
20,
889-898
|
| 41.
|
De Waard, M.,
Pragnell, M.,
and Campbell, K. P.
(1994)
Neuron
13,
495-503
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.